AesRx Aims at Two Rare Diseases In Growing Orphan Drug Market
The Newton, Mass.-based biopharmaceutical company is developing a small-molecule drug for sickle cell disease.
The Newton, Mass.-based biopharmaceutical company is developing a small-molecule drug for sickle cell disease.
A researcher at the University of Adelaide found that people suffering from inflammatory bowel disease have a lower number of regulatory cells that control the immune system.
That little houseplant sitting on your windowsill could one day save your life.
Copyright © 2024 | WordPress Theme by MH Themes